Origin Pharma Packaging have been shortlisted for ‘Use of Tech in a Traditional Business‘ at the Hull & Humber Tech Awards 2019. The Perennial Encryption technology we have developed is for clinical trials (improving adherence and generating accurate results) and tracking drug products across the globe at any point of the supply chain (reducing counterfeit…
Origin joins new facility in world-class science campus Alderley Park to work with UK pharma start-ups
Global pharmaceutical solutions provider, Origin, has announced it’s opening a second UK facility in Alderley Park, the world-class science campus in the North of England. Origin has invested heavily in its New Product Development and Innovation department at its HQ in Melton, East Riding of Yorkshire over the past 24 months and the new facility…
What Does the Future Hold for Clinical Trials
We often here talk about digital technology having the capacity to transform and modernise the life science industry. But on a practical level what does this actually mean and moreover when will this market shift begin to come to fruition? The following insight is Origin’s perspective on the likely changes which will be imparted across…
Artificial Intelligence: What it means to pharma
Following its fast-paced development in recent years, AI is transforming the future of industries. For pharma, in particular, AI is becoming an integral element of drug discoveries, device and packaging design, treatment plans and the pharmaceutical supply chain. Enabling the industry to operate with increased accuracy and efficiency, AI has the potential to be the…
Act Now. Not Later. Compliant Child Resistant Packaging.
One of our strongest values is protecting children from harmful substances and to ensure that all ‘CR’ packaging is compliant and has gone through the necessary testing. We are on a mission to encourage all brand and license holders on an international scale, to take responsibility in protecting child from their product in the domestic…
The role of pre-filled syringes in delivering the personalised drug revolution
The future of medicine is personalised, based on treating individuals for their risk factors and replacing the traditional universal medicine approach. A leading tool in the delivery of personalised medicine is pre-filled syringes, with over 10.2 million units expected to be sold worldwide by 2026. Pre-filled syringes are revolutionising the way medicine is controlled, delivered…
Top 10 Pipeline Drugs To Watch in 2019
Der Prozess der Arzneimittelentwicklung
When a new drug hits the development stage it can go through a lengthy and complex process before it is seen by the public or distributed to pharmacies. In reality, only two tested innovations out of 10,000 actually become fully licensed treatments. All in all, it can take an average of ten to fifteen years…
WHO is W.H.O.?
Sunday, April 7th is World Health Day, an annual campaign built to increase global awareness of universal health coverage with a particular focus on what services should be available. The event Is organized by the World Health Organization, and signals a major date in their calendar. But exactly who is WHO, and what are their…
The Impacts of Brexit on the UK Pharma Industry
Origin Pharma Contributed an article to EPM Magazine – full story below Like every industry, the pharma sector is poised on the edge of its seat in anticipation of a final agreement on Brexit. The UK will officially leave the European Union on March 29th (if all goes to plan) and the terms of the…